U.S. Markets closed

Varian Medical sell-off would be buying opportunity, says RW Baird

Baird believes Varian Medical management's cautious tone may cause a sell-off in the shares but would use it as a buying opportunity. The firm noted the in-line Q2 results and the near-term uncertainty in the US but believes the company remains a double digit earnings grower. Baird maintains its Outperform rating but lowered its price target to $76 from $82.